FRANCOIS CEDRIC (Chief Executive Officer) sold 8.7% of their position (27.19K shares) of APELLIS PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $591.8K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/23/2026ACC: 0001492422-26-000057
DirectorOfficer· Chief Executive Officer
Since Feb 2019
-27.19K
Net shares
Net seller
$591.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
27.19K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−27.19K
Price / share
$21.77
Trade value
$591.84K
% of position
8.7%
1/22/2026
313.24K→286.05K
Total
Net shares
−27.19K
Net value
-$591.84K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/22/2026 | S · Sale | −27.19K | $21.77 | $591.84K | 8.7% | 313.24K | 286.05K |
| Total | −27.19K | -$591.84K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)4
Common Stock
IndirectShares owned234.41K
Common Stock
IndirectShares owned300K
Common Stock
IndirectShares owned472.06K
Common Stock
IndirectShares owned307.95K
Total
1.31M indirect1.31M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 234.41K | Indirect |
| Common Stock | 300K | Indirect |
| Common Stock | 472.06K | Indirect |
| Common Stock | 307.95K | Indirect |
| Total | 1.31M | 1.31M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported